Stocks and Investing Stocks and Investing
Fri, March 22, 2024
[ 12:00 AM ] - United States, WOPRAI
Ashwin Shirvaikar Maintained (ACN) at Strong Buy with Decreased Target to $400 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Ketan Mamtora Maintained (WY) at Hold with Increased Target to $38 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Gabriel Gusan Maintained (XP) at Strong Buy with Increased Target to $29 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Swayampakula Ramakanth Reiterated (XFOR) at Strong Buy and Held Target at $3 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Dana Telsey Maintained (YOU) at Buy and Held Target at $34 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Allen Klee Upgraded (ccld) to Strong Buy and Held Target at $3 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Nicholas Joseph Downgraded (cdp) to Hold and Decreased Target to $25 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Amit Daryanani Maintained (CDW) at Buy with Increased Target to $300 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Michael Sison Maintained (CE) at Buy with Increased Target to $195 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrigan Maintained (SMSI) at Strong Buy with Decreased Target to $20 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Ki Bin Kim Maintained (SPG) at Hold with Increased Target to $147 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Charles Shi Reiterated (SNPS) at Strong Buy and Held Target at $660 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Austin Moeller Maintained (SPIR) at Strong Buy with Decreased Target to $24 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Jason Bazinet Maintained (SRAD) at Strong Buy with Increased Target to $17 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Brian Lee Downgraded (STEM) to Hold and Decreased Target to $2.5 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Matt O"Brien Maintained (TELA) at Buy with Decreased Target to $12 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
David Turkaly Reiterated (TELA) at Buy and Held Target at $15 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Paul Johnson Maintained (TCPC) at Hold with Decreased Target to $11 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Derrick Whitfield Reiterated (TALO) at Strong Buy with Decreased Target to $17 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Paul Diamond Initiated (TALO) at Strong Buy and Held Target at $17 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Initiated (TAP) at Hold and Held Target at $69 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Initiated (STZ) at Buy and Held Target at $300 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Alexander Goldfarb Maintained (TRNO) at Buy with Increased Target to $73 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Mircea Dobre Maintained (TITN) at Hold with Decreased Target to $24 on, Mar 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Casey Alexander Upgraded (TPVG) to Hold and Held Target at $8.75 on, Mar 22nd, 2024
Thu, March 21, 2024
[ 12:00 AM ] - United States, WOPRAI
Tyler Batory Maintained (TOL) at Buy with Increased Target to $157 on, Mar 21st, 2024
[ 12:00 AM ] - United States, WOPRAI
Geulah Livshits Reiterated (TNYA) at Strong Buy and Held Target at $20 on, Mar 21st, 2024
[ 12:00 AM ] - United States, WOPRAI
Judy Zhang Maintained (TIGR) at Strong Buy with Decreased Target to $6.22 on, Mar 21st, 2024
[ 12:00 AM ] - United States, WOPRAI
Bryan Blair Reiterated (TKR) at Buy with Increased Target to $100 on, Mar 21st, 2024
[ 12:00 AM ] - United States, WOPRAI
Leland Gershell Maintained (TRVI) at Buy and Held Target at $9 on, Mar 21st, 2024

Leland Gershell Maintained (TRVI) at Buy and Held Target at $9 on, Mar 21st, 2024


Published on 2024-10-28 09:50:13 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "Trevi Therapeutics, Inc." (TRVI) at Buy and Held Target at $9 on, Mar 21st, 2024.

Leland, nor any peers, have made any analyst calls on TRVI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources